When did Novavax report Q4 2024 earnings?

Novavax (NVAX) reported Q4 2024 earnings on February 27, 2025 before market open.

What were Novavax's Q4 2024 revenue and EPS?

Novavax reported revenue of $88.3M and eps of $-0.51 for Q4 2024.

Did Novavax beat estimates in Q4 2024?

Revenue beat the consensus estimate of $84.4M by $3.9M. EPS beat the consensus estimate of $-0.75 by $0.24.

Where can I find Novavax's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001000694-25-000004) directly on SEC EDGAR. The filing index links above go to sec.gov.

Novavax NVAX Q4 2024 Annual earnings

Reported February 27, 2025 · Before market open

Revenue$88.3MBeat by $3.9M

EPS-$0.51Beat by $0.24

Revenue estimate$84.4M

EPS estimate-$0.75

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$52.1M

EPS estimate-$0.40

Financials

Q4 2024

Income statement

See full

Revenue$88.3M-69.7%

Gross profit$51.6M-62.1%

Operating income-$131.1M+28.6%

Net income-$81.0M+54.6%

EPS (diluted)-$0.52+64.6%

Balance sheet

See full

Cash & equivalents$530.2M-6.7%

Total debt$100.8M-42.0%

Total equity-$623.8M+13.0%

Total assets$1.6B-13.2%

Cash flow

See full

Operating cash flow-$173.2M+2.0%

CapEx$1.9M-78.1%

Free cash flow-$175.1M+5.7%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.29B+126%

Enterprise value$858.45M+390%

P/S1.9×+1.3×

Profitability

See full

Gross margin70.3%+5.2pp

Operating margin-36.5%-9.8pp

Net margin-27.5%-9.2pp

FCF margin-14.7%-6.6pp

Returns & leverage

See full

Current ratio1×+0.3×

Segments

By geography

See full

Rest of the world$18.4M-71.0%

Europe$2.1M-96.9%

Rest of North America$1.1M—

By segment

See full

Reportable Segment$88.3M-64.1%

Versus estimates

Revenue

Q1 2026$139.5MBeat by $59.7M Q4 2025$147.1MBeat by $57.3M Q3 2025$70.4MMiss by $19.8M Q2 2025$239.2MBeat by $183.6M Q1 2025$666.7MBeat by $322.8M

Q4 2024$88.3MBeat by $3.9M

Diluted EPS

Q1 2026-$0.06Beat by $0.19 Q4 2025$0.11Beat by $0.77 Q3 2025-$0.62Beat by $0.46 Q2 2025$0.62Beat by $0.69 Q1 2025$2.93Beat by $2.22

Q4 2024-$0.51Beat by $0.24

Ask the moment Novavax reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Novavax report Q4 2024 earnings?: Novavax (NVAX) reported Q4 2024 earnings on February 27, 2025 before market open.
What were Novavax's Q4 2024 revenue and EPS?: Novavax reported revenue of $88.3M and eps of $-0.51 for Q4 2024.
Did Novavax beat estimates in Q4 2024?: Revenue beat the consensus estimate of $84.4M by $3.9M. EPS beat the consensus estimate of $-0.75 by $0.24.
Where can I find Novavax's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001000694-25-000004) directly on SEC EDGAR. The filing index links above go to sec.gov.